J Pediatr Intensive Care 2017; 06(02): 083-090
DOI: 10.1055/s-0036-1584909
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Characterization of Tolerance in Children during Fentanyl Continuous Infusions

Bethany W. Ibach
1   Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, Texas, United States
,
Jamie L. Miller
2   Department of Pharmacy: Clinical and Administrative Sciences, The University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma, United States
,
Sukyung Woo
3   Department of Pharmaceutical Sciences, The University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma, United States
,
Donald Harrison
2   Department of Pharmacy: Clinical and Administrative Sciences, The University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma, United States
,
Kelly M. Standifer
3   Department of Pharmaceutical Sciences, The University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma, United States
,
Tracy Hagemann
4   Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Nashville, Tennessee, United States
,
Peter N. Johnson
2   Department of Pharmacy: Clinical and Administrative Sciences, The University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

10. Juni 2015

11. Dezember 2015

Publikationsdatum:
29. Juni 2016 (online)

Zoom Image

Abstract

Tolerance is a complication of fentanyl continuous infusions (CINs) in critically ill children, but the incidence and time of onset are lacking. The primary objective was to identify the incidence of tolerance. Secondary objectives were to determine the onset time and compare risk factors between children with tolerance versus no tolerance and between children with early (< 24 hours) versus late tolerance. Children aged 0 to 17 years, receiving fentanyl CIN > 3 days from May 1, 2012 to June 30, 2013 were included. Tolerance was defined as a doubling of the fentanyl CIN dose. Descriptive and inferential statistics were performed. A logistic regression model was used to assess the relationship between the development of tolerance and independent variables. A total of 59 CINs were included. Tolerance occurred in 46 CINs (78%), with median time to tolerance of 26 hours (range: 1–160 hours). Early tolerance was identified in 21 CINs (45.7%). Patients with tolerance had higher peak CIN doses (p < 0.001), final CIN doses (p = 0.031), and cumulative exposure (p = 0.017). No significant differences were noted between those with early versus late tolerance. The regression model noted factors associated with the odds of development of tolerance were lower initial fentanyl dose (p = 0.007; odds ratio [OR]: 0.011, 95% confidence interval [CI]: 0.0004–0.29) and higher cumulative exposure (p = 0.009; OR: 1.01, 95% CI: 1.001–1.01). Tolerance developed in 78% of children, and half developed it within 24 hours. Lower initial opioid dose and higher cumulative exposure were independently associated with tolerance.

Note

At the time of data collection and article preparation, Dr. Ibach was a PGY2 resident at the College of Pharmacy, University of Oklahoma.